American Journal of Law and Medicine
American Journal of Law and Medicine is a journal indexed in SJR in Medicine (miscellaneous) and Health (social science) with an H index of 36. It has a price of 3971,1 €. It has an SJR impact factor of 0,219 and it has a best quartile of Q3. It is published in English. It has an SJR impact factor of 0,219.
Metrics
Scimago and CountryOfPapers database fields
SJR Impact
0,219
H-index
36
Docs (year)
10
Docs 3y
88
Total refs
1408
Cites 3y
66
Citable 3y
88
Cites/Doc 2y
0.44
Ref/Doc
140.8
Immediate OA
3971,1 €
Embargoed OA
NPD
Non OA / Submission
0 €
Name good journals. Call out predatory ones.
Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.
Researcher reviews
Best articles by citations
Cells as Drugs?: Regulating the Future of Medicine
View moreWhen the First Amendment and Public Health Collide: The Court's Increasingly Strict Constitutional Scrutiny of Health Regulations That Restrict Commercial Speech
View moreEfficient Prosecution of False Claims Act Violations May Help Relieve The Current Opioid Crisis
View moreEbola Again Shows the International Health Regulations Are Broken
View moreDo You Own Your 3D Bioprinted Body?
View moreDigital Manipulation of Images of Models' Appearance in Advertising: Strategies for Action Through Law and Corporate Social Responsibility Incentives to Protect Public Health
View moreDietary Supplement Labeling: Cognitive Biases, Market Manipulation & Consumer Choice
View moreDemanding Individually Safe Drugs Today: Overcoming the Cross-Labeling Legal Hurdle to Pharmacogenomics
View moreDefining a Standard of Care in the Practice of Acupuncture
View moreDeficiencies of the FDA in Evaluating Generic Formulations: Addressing Narrow Therapeutic Index Drugs
View moreCultura Obscura: Race, Power, and "Culture Talk" in the Health Sciences
View moreConfronting the Vector of Tobacco-Related Disease
View moreCommercial Speech Law and Tobacco Marketing: A Comparative Discussion of the United States and Canada
View more"Since I Must Please Those Below"
View moreCelebrity Drug Endorsements
View moreBiting the Hands that Feed "the Alligators": A Case Study in Morbid Obesity Extremes, End-of-Life Care, and Prohibitions on Harming and Accelerating the End of Life
View moreBeyond Payment and Delivery Reform: The Individual Mandate's Cost-Control Potential
View moreBaby M Turns 30: The Law and Policy of Surrogate Motherhood
View moreAssessing the True Impact of the ACA: Revisiting the CBO's Initial Predictions
View moreAre We Suffering from an Undiagnosed Health Right?
View moreAIDS Activists, FDA Regulation, and the Amendment of America's Drug Constitution
View moreA RAT by Another Name: 21st Century Cures Act and Stem Cell Therapies
View more21st Century Cures for the Opioid Crisis: Promise, Impact, and Missed Opportunities
View more21st Century Cures Act and Medical Device Regulation Departure from Principles or Catching the Wave
View more